← Evidence map

ArticleCancer immunology research2026

FOXM1-Specific TCR-Engineered T Cells Target Non-Small Cell Lung Cancer.

Emily Bontekoe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41854516